Hum. Reprod. Advance Access published online on August 27, 2004
Human Reproduction, doi:10.1093/humrep/deh462
© 2004 by European Society of Human Reproduction and Embryology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Genetics, Faculty of Medicine, Porto, Portugal
* To whom correspondence should be addressed. E-mail: msousa{at}icbas.up.pt.
BACKGROUND: Cystic fibrosis conductance transmembrane regulator (CFTR) gene mutations and IVS8 poly(T) variants in Portuguese patients with bilateral (CBAVD) and unilateral (CUAVD) congenital absence of the vas deferens remain to be evaluated. METHODS: Patient screening was carried out by PCR, denaturing gradient gel electrophoresis and DNA sequencing. RESULTS: CFTR mutations were found in 18 out of 31 (58.1%) CBAVD and in three of four (75%) CUAVD patients. The most frequent mutations were F508del and R334W in CBAVD and G542X in CUAVD, with the allelic frequencies of R334W (6.5%) and G542X (25%) being particular to the Portuguese population. The 5T allelic frequency was 3.5% in the fertile male population, 25% in CUAVD and 27.4% in CBAVD patients. The combined frequency of mutations (CFTR+5T) was increased in CBAVD to 22 out of 31 (71%). The frequency of CFTR mutations was compared with that of patients with secondary obstructive azoospermia (OAZ; one out of 16, 6.3%) and non-obstructive azoospermia (NOAZ; two out of 22, 9.1%) with conserved spermatogenesis, which were similar to the general population. However, whereas the 5T allelic frequency in OAZ was similar to that of the general population (3.1%), it was increased in NOAZ cases (14.3%). CONCLUSIONS: Data confirm that CFTR+5T mutations represent the most common genetic abnormality in CAVD, and suggest that cases of NOAZ may be associated with the 5T allele.
Revised April 29, 2004
Accepted July 16, 2004
Article
Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens
2 Department of Biochemistry and Genetics, Henri Mondor Hospital, Creteil, France
3 Department of Genetics, Faculty of Medicine, Porto, Portugal; Centre for Reproductive Genetics Alberto Barros, Porto, Portugal
4 Centre for Reproductive Genetics Alberto Barros, Porto, Portugal
5 Department of Genetics, Faculty of Medicine, Porto, Portugal; Centre for Reproductive Genetics Alberto Barros, Porto, Portugal; Laboratory of Cell Biology, ICBAS, University of Porto, Porto, Portugal
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Sharma, N. Acharya, S.K. Singh, M. Singh, U. Sharma, and R. Prasad Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens Hum. Reprod., May 1, 2009; 24(5): 1229 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ratbi, M. Legendre, F. Niel, J. Martin, J.-C. Soufir, V. Izard, B. Costes, C. Costa, M. Goossens, and E. Girodon Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling Hum. Reprod., May 1, 2007; 22(5): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Radpour, M. A. S. Gilani, H. Gourabi, A. V. Dizaj, and S. Mollamohamadi Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens Mol. Hum. Reprod., July 1, 2006; 12(7): 469 - 473. [Abstract] [Full Text] [PDF] |
||||

